Literature DB >> 5478953

Tryptophan metabolism in depression.

G Curzon, P K Bridges.   

Abstract

Psychiatric patients suffering from endogenous depression and a control group without endogenous depression were given oral loads of L-tryptophan and urinary excretion determined of the tryptophan metabolites on the pyrrolase pathway: kynurenine, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid. Female endogenously depressed subjects excreted significantly more kynurenine and 3-hydroxykynurenine but not the subsequent metabolite 3-hydroxyanthranilic acid than did female control subjects. Variability of excretion of kynurenine and 3-hydroxykynurenine at different times by the same subject was much greater in the endogenously depressed than in the control group. There was no consistent temporal relationship between excretion of metabolites and severity of the depressive illness. The possible significance of the findings in relation to defective tryptophan metabolism in the brain in endogenous depression is commented upon.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5478953      PMCID: PMC493552          DOI: 10.1136/jnnp.33.5.698

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  35 in total

1.  [THE SIGNIFICANCE OF MONOAMINE OXIDASE INHIBITION AS AN ANTIDEPRESSIVE PRINCIPLE. I].

Authors:  B LEIJNSE
Journal:  Psychopharmacologia       Date:  1963-02-22

2.  THE DIURNAL PATTERN OF SALIVARY FLOW IN NORMAL AND DEPRESSED PATIENTS.

Authors:  G PALMAI; B BLACKWELL
Journal:  Br J Psychiatry       Date:  1965-04       Impact factor: 9.319

3.  Emotional and adrenal cortical responses to a new experience. Effect of social environment.

Authors:  J R FISHMAN; D A HAMBURG; J H HANDLON; J W MASON; E SACHAR
Journal:  Arch Gen Psychiatry       Date:  1962-04

4.  Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases.

Authors:  J M PRICE; R R BROWN; H A PETERS
Journal:  Neurology       Date:  1959-07       Impact factor: 9.910

5.  The determination in urine of some metabolites of tryptophankynurenine, anthranilic acid and 3-hydroxyanthranilic acid- and reference to the presence of o-aminophenol in urine.

Authors:  S L TOMPSETT
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

6.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

Authors:  G W Ashcroft; T B Crawford; D Eccleston; D F Sharman; E J MacDougall; J B Stanton; J K Binns
Journal:  Lancet       Date:  1966-11-12       Impact factor: 79.321

7.  Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

Authors:  H R Bourne; W E Bunney; R W Colburn; J M Davis; J N Davis; D M Shaw; A J Coppen
Journal:  Lancet       Date:  1968-10-12       Impact factor: 79.321

Review 8.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

9.  Adrenal cortical activity changes in manic-depressive illness. Influence on intermediary metabolism of tryptophan.

Authors:  R T Rubin
Journal:  Arch Gen Psychiatry       Date:  1967-12

10.  [Urinary excretion of 5-hydroxyindolacetic acid (5-HIAA) in 150 patients with depressive syndrome and maniacal agitation. (Its modifications by 5-hydroxy-tryptophan loading and therapy in the depressive states)].

Authors:  J J BURGERMEISTER; P DICK; G GARONNE; M GUGGISBERG; R TISSOT
Journal:  Presse Med       Date:  1963-05-04       Impact factor: 1.228

View more
  21 in total

Review 1.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

2.  NextGen Brain Microdialysis: Applying Modern Metabolomics Technology to the Analysis of Extracellular Fluid in the Central Nervous System.

Authors:  Chi-Ya Kao; Elmira Anderzhanova; John M Asara; Carsten T Wotjak; Christoph W Turck
Journal:  Mol Neuropsychiatry       Date:  2015-04-29

3.  Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?

Authors:  Mandy Busse; Stefan Busse; Aye Mu Myint; Tomasz Gos; Henrik Dobrowolny; Ulf J Müller; Bernhard Bogerts; Hans-Gert Bernstein; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-20       Impact factor: 5.270

4.  A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls.

Authors:  Samuel J DeWitt; Kailyn A Bradley; Na Lin; Chunli Yu; Vilma Gabbay
Journal:  J Affect Disord       Date:  2017-11-20       Impact factor: 4.839

5.  Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan.

Authors:  S E Moller; L Kirk; K H Fremming
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

6.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

7.  The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.

Authors:  Kailyn A L Bradley; Julia A C Case; Omar Khan; Thomas Ricart; Amira Hanna; Carmen M Alonso; Vilma Gabbay
Journal:  Psychiatry Res       Date:  2015-04-01       Impact factor: 3.222

8.  The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

Authors:  Vilma Gabbay; Leonard Liebes; Yisrael Katz; Songtao Liu; Sandra Mendoza; James S Babb; Rachel G Klein; Oded Gonen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-21       Impact factor: 5.067

9.  Regional and subcellular changes in the concentration of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat brain caused by hydrocortisone, DL- -methyl-tryptophan l-kynurenine and immobilization.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

10.  The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine.

Authors:  S L Handley; R C Miskin
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.